1. Gemmati D, Bramanti B, Serino ML, Secchiero P, Zauli G, Tisato V. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males? (2020) 21(10):3474.
2. Hou Y, Zhao J, Martin W, Kallianpur A, Cheng F. New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Medicine (2020) 18(1):216.
3. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Phlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell (2020) 181(2):271-280.
4. Narayanappa A, Chastain WH, Paz M, Solch RJ, Bix G. SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders. Cytokine & Growth Factor Reviews (2021) 58 (3):1-15.
5. Achar A, Ghosh C. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance. Cells (2020) 9(11):2360.
6. Nakagawa, T. Cathepsin L: Critical Role in Ii Degradation and CD4 T Cell Selection in the Thymus. Science (1998) 280(5362):450-3.
7. Brady CP, Brinkworth RI, Dalton JP, Dowd AJ, Verity CK, Brindley PJ. Molecular Modeling and Substrate Specificity of Discrete Cruzipain-like and Cathepsin L-like Cysteine Proteinases of the Human Blood Fluke Schistosoma mansoni. Archives of Biochemistry & Biophysics (2000) 380(1):46-55.
8. Sudhan DR, Siemann DW. Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells. Clinical & Experimental Metastasis (2013) 30(7):891-902.
9. Yao F, Xiong Y, Xiao S, Zhao Y, Ying Z, Long W, et al. Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway. Cellular Signalling (2018) 44:62.
10. Sigloch FC, Tholen M, Gomez-Auli A, Biniossek ML, Reinheckel T, Schilling O. Proteomic analysis of lung metastases in a murine breast cancer model reveals divergent influence of CTSB and CTSL overexpression. Journal of Cancer (2017) 8(19):4065-74.
11. Shan Y, Yu Y, Wen Z, Wei Y, Liu T. FOXO3a promotes gastric cancer cell migration and invasion through the induction of cathepsin L. Oncotarget (2016) 7(23).
12. Sudhan DR, Rabaglino MB, Wood CE, Siemann DW. Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94. Clinical & Experimental Metastasis (2016) 33(5):461-73.
13. Leskowitz S, Phillipino L, Hendrick G, Graham JB. Immune response in patients with cancer. Cancer (2015) 10(6):1103-5.
14. Addeo A, Friedlaender A. Cancer and COVID-19: unmasking their ties. Cancer Treatment Reviews (2020) 88:102041.
15. Bao R, Hernandez K, Huang L, Luke JJ. ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-COV-2 COVID-19. J Immunother Cancer (2020) 8(2):e001020.
16. Deng X, Lin D, Zhang X, Shen X, Yang Z, Yang L, et al. Profiles of immune-related genes and immune cell infiltration in the tumor microenvironment of diffuse lower-grade gliomas. Journal of cellular physiology (2020) 235(10):7321-31.
17. Xie M, Chen Q. Insight into 2019 novel coronavirus — an updated intrim review and lessons from SARS-CoV and MERS-CoV. International Journal of Infectious Diseases (2020) 94:119-124.
18. Chen, Jiawei, Peiyi, Zeguang. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med (2020) (2):185-192.
19. Vargas-Alarcón G, Posadas-Sánchez R, Ramírez-Bello J. Variability in genes related to SARS-CoV-2 entry into host cells (ACE2, TMPRSS2, TMPRSS11A, ELANE, and CTSL) and its potential use in association studies. Life Sciences (2020) 260:118313.
20. Jacobo R, Pangua C, Serrano-Montero G, Obispo B, Lara MN. Covid-19 and lung cancer: A greater fatality rate? Lung Cancer (2020) 146:19-22.
21. Kwan J, Lin LT, Bell R, Bruce JP, Liu FF. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Scientific reports (2021) 11(1):4533.
22. Zhou Y, Hou Y, Shen J, Huang Y, Cheng F. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery. (2020) 16(6):14.
23. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA The Journal of the American Medical Association (2020) 323(18):1824-1836.
24. Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nature reviews Immunology (2020) 20(6):1-8.
25. Savarino A, Trani LD, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infectious Diseases (2006) 6(2):67-9.
26. Wang H, Zhang L. Risk of COVID-19 for patients with cancer. The Lancet Oncology (2020) 21(4):e180.
27. Qin C, Zhou L, Hu Z, Zhang S, Tian DS. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clinical Infectious Diseases (2020) 71(15):762-768..
28. Wang Z, Xiang Z, Zhu T, Chen J, Zhou W. CathepsinL interacts with CDK2AP1 as a potential predictor of prognosis in patients with breast cancer. Oncology letters (2019) 19(1) :167-176.
29. Wang W, Long LM, Wang L, Tan C, Feng X, Chen X, Liang Z. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro. Cancer Letters (2016) 371(2):274-84.
30. Qin G, Cai Y, Long J, Zeng H, Xu W, Li Y, Liu M, Zhang H, He ZL, Chen WG. Cathepsin L is involved in proliferation and invasion of breast cancer cells. Neoplasma: Journal of Experimental and Clinical Oncology (2016) 63(1):30-6.